MedPath

Evaluation of the effect of targeted mild therapeutic hypercapnia during and after cardiopulmonary bypass on cerebral oxygenation and neuropsychological outcomes

Not Applicable
Completed
Conditions
Cardiac surgery
Low cerebral oxygenation
Cardiovascular - Other cardiovascular diseases
Registration Number
ACTRN12616000111471
Lead Sponsor
Austin Health
Brief Summary

Trend towards benefit of targeted mild therapeutic hypercapnia (slightly higher than normal targeting of blood carbon dioxide level) on cerebral oxygenation during cardiopulmonary bypass; non-inferior safety outcomes of intervention; finding of ongoing cerebral oxygen desaturation post-operatively across both intervention & control groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
31
Inclusion Criteria

1. Admitted to the Austin Hospital for elective cardiac surgery
2. Aged 18 years or older
3. Able to speak and read English

Exclusion Criteria

1. Pre-operative Mini-Mental State Examination score < 24
2. Emergency cases
3. History of neuropsychiatric disorders
4. Contraindications to increased CO2 levels, such as right-sided heart failure, pulmonary hypertension, metabolic acidosis
5. Aortic arch surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cerebral oxygenation as measured by Near-Infrared Spectroscopy[Five-minutely over the course of the surgery, fifteen-minutely over the 12 hours post-operatively, and continuously for a period of five minutes on days 2 and 3 post-operatively]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath